iSpecimen Inc
NASDAQ:ISPC
Balance Sheet
Balance Sheet Decomposition
iSpecimen Inc
iSpecimen Inc
Balance Sheet
iSpecimen Inc
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
1
|
0
|
1
|
28
|
15
|
2
|
2
|
|
| Cash |
1
|
0
|
1
|
28
|
15
|
2
|
2
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
3
|
0
|
|
| Total Receivables |
1
|
1
|
2
|
5
|
4
|
3
|
1
|
|
| Accounts Receivables |
1
|
1
|
2
|
5
|
4
|
3
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
2
|
2
|
3
|
33
|
20
|
8
|
4
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
1
|
2
|
3
|
3
|
5
|
7
|
5
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
4
N/A
|
4
+4%
|
6
+48%
|
36
+475%
|
25
-31%
|
16
-36%
|
9
-41%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
1
|
2
|
1
|
2
|
4
|
4
|
|
| Accrued Liabilities |
1
|
2
|
5
|
1
|
2
|
2
|
1
|
|
| Short-Term Debt |
7
|
11
|
12
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
3
|
2
|
3
|
1
|
0
|
0
|
0
|
|
| Total Current Liabilities |
11
|
16
|
22
|
3
|
4
|
6
|
6
|
|
| Long-Term Debt |
0
|
0
|
0
|
3
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
11
N/A
|
16
+39%
|
22
+42%
|
6
-73%
|
4
-27%
|
6
+41%
|
6
-1%
|
|
| Equity | ||||||||
| Common Stock |
11
|
11
|
11
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
20
|
24
|
29
|
38
|
48
|
59
|
72
|
|
| Additional Paid In Capital |
1
|
2
|
2
|
68
|
69
|
69
|
75
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
7
N/A
|
12
-59%
|
16
-39%
|
30
N/A
|
20
-32%
|
10
-52%
|
3
-66%
|
|
| Total Liabilities & Equity |
4
N/A
|
4
+4%
|
6
+48%
|
36
+475%
|
25
-31%
|
16
-36%
|
9
-41%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
6
|
6
|
6
|
9
|
9
|
0
|
2
|
|